GPN VACCINES, INC. — Form D

GPN VACCINES, INC. of WILMINGTON, DE, a company, filed a Form D exempt-offering notice with the SEC on 2026-01-28. The offering totals $10.0M, of which $3.5M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-01-28
• Form: D
• Accession: 0002105609-26-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $10.0M
• Amount sold: $3.5M
• Remaining: $6.5M
• Minimum investment: $228
• Investors: 63
• Date of first sale: 2025-12-24
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-571402

Issuer

• Name: GPN VACCINES, INC.
• CIK: 0002105609
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2025
• Address: 251 LITTLE FALLS DRIVE, WILMINGTON, DE, 19808
• Phone: 61 420 942 8224

Officers, directors & promoters (3)

More

• CIK 2105609 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search